Quince Therapeutics, Inc. (QNCX)

1.38 +0.04 (+2.99%) USD  |  NASDAQ  |  Apr 22, 16:00
1.35 -0.03 (-2.17%) After-Hours: 19:41
More

Quince Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
Ocular Therapeutix, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade